Cited by 3,184Cancer Genomics and DiagnosticsCancer-related Molecular PathwaysGenomics and Rare Diseases

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

A census of human cancer genes

Open access

Futreal, P. Andrew, Coin, Lachlan, Marshall, Mhairi, Down, Thomas, Hubbard, Timothy, Wooster, Richard, Rahman, Nazneen, Stratton, Michael R.·2004·Nature Reviews Cancer

DOI 10.1038/nrc1299PMC PMC2665285

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc1299

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Pfam Protein Families Database
Bateman, A. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,075
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A. U., McGreevey, L. S., Chen, C.-J., Joseph, N. E., Singer, S., Griffith, D., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,297
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R. E., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,271
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Self-citation

Show all 44 references

Sorted by citations

Items 401–500 of 1,007

Overexpression of Eg5 Causes Genomic Instability and Tumor Formation in Mice
Castillo, A., Morse, H. C., Godfrey, V., Naeem, R., & Justice, M. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0326 · Cited by 155
The Genomic Landscape of Male Breast Cancers
Piscuoglio, S., Ng, C. K. Y., Murray, M. P., Guerini‐Rocco, E., Martelotto, L. G., Geyer, F. C., Bidard, F., Berman, S., Fusco, N., Sakr, R. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2840 · Cited by 152
Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomesPreprint
Kim, T., Xi, R., Luquette, L. J., Park, R. W., Johnson, M. D., & Park, P. J. (2012) · Genome Research · doi:10.1101/gr.140301.112 · Cited by 152
LINE-1 expression and retrotransposition in Barrett’s esophagus and esophageal carcinoma
Doucet-O’Hare, T. T., Rodić, N., Sharma, R., Darbari, I., Abril, G., Choi, J. A., Ahn, J. Y., Cheng, Y., Anders, R. A., Burns, K. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502474112 · Cited by 158
Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles
Bertrand, D., Chng, K. R., Sherbaf, F. G., Kiesel, A., Chia, B. K. H., Sia, Y. Y., Huang, S. K., Hoon, D. S. �., Liu, E. T., Hillmer, A. M., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1393 · Cited by 152
Recurrent targets of aberrant somatic hypermutation in lymphoma
Khodabakhshi, A. H., Morin, R. D., Fejes, A. P., Mungall, A. J. J., Mungall, K. L., Bolger-Munro, M., Johnson, N. A., Connors, J. M., Gascoyne, R. D., Marra, M. A., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.653 · Cited by 159
Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers
Guo, Y. A., Chang, M. M., Huang, W., Ooi, W. F., Xing, M., Tan, P. B. O., & Skanderup, A. J. (2018) · Nature Communications · doi:10.1038/s41467-018-03828-2 · Cited by 149
RETRACTED ARTICLE: CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus
Bernard, D., Martínez-Leal, J. F., Rizzo, S., Martínez, D., Hudson, D. L., Visakorpi, T., Peters, G. G., Carnero, A., Beach, D., & Gil, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208735 · Cited by 149
Retracted
Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases
Wang, D., Niu, X., Wang, Z., Song, C., Huang, Z., Chen, K., Duan, J., Bai, H., Xu, J., Zhao, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1086 · Cited by 149
Does Patent Strategy Shape the Long-Run Supply of Public Knowledge? Evidence from Human Genetics
Huang, K. G.-L., & Murray, F. (2009) · Academy of Management Journal · doi:10.5465/amj.2009.47084665 · Cited by 147
Helicobacter pylori Infection Causes Characteristic DNA Damage Patterns in Human Cells
Koeppel, M., García-Alcalde, F., Glowinski, F., Schlaermann, P., & Meyer, T. F. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.030 · Cited by 153
Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia
Atak, Z. K., Gianfelici, V., Hulselmans, G. J., Keersmaecker, K. D., Devasia, A. G., Geerdens, E., Mentens, N., Chiaretti, S., Durinck, K., Uyttebroeck, A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003997 · Cited by 149
Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance
Bishop, R. (2010) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzq009 · Cited by 157
COSMIC: High‐Resolution Cancer Genetics Using the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Beare, D. M., Bindal, N., Bamford, S., Ward, S., Cole, C. G., Jia, M., Kok, C. Y., Boutselakis, H., De, T., et al. (2016) · Current Protocols in Human Genetics · doi:10.1002/cphg.21 · Cited by 149
SF3B1 mutations in chronic lymphocytic leukemia
Wan, Y., & Wu, C. J. (2013) · Blood · doi:10.1182/blood-2013-02-427641 · Cited by 155
Analysis of next-generation genomic data in cancer: accomplishments and challenges
Ding, L., Wendl, M. C., Koboldt, D. C., & Mardis, E. R. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq391 · Cited by 148
Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns
Yang, X., Gao, L., & Zhang, S. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw063 · Cited by 147
Locus-specific mutation databases: pitfalls and good practice based on the p53 experience
Soussi, T., Ishioka, C., Claustres, M., & Béroud, C. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1783 · Cited by 144
Infection Exposure Is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5 -Inherited Susceptibility
Martín‐Lorenzo, A., Hauer, J., Vicente‐Dueñas, C., Auer, F., González‐Herrero, I., García‐Ramírez, I., Ginzel, S., Thiele, R., Constantinescu, S. N., Bartenhagen, C., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0892 · Cited by 144
Multiplex Ligation-dependent Probe Amplification (MLPA) in Tumor Diagnostics and Prognostics
Cornelia, H.-H., & Savola, S. P. (2012) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3182595516 · Cited by 144
Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
Yan, T., Cui, H., Zhou, Y., Yang, B. J., Kong, P., Zhang, Y., Liu, Y., Wang, B., Cheng, Y., Li, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09255-1 · Cited by 145
Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma
Wong, K., van der Weyden, L., Schott, C. R., Foote, A. K., Constantino‐Casas, F., Smith, S., Dobson, J. M., Murchison, E. P., Wu, H. G., Yeh, I., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08081-1 · Cited by 145
Exon Array CGH: Detection of Copy-Number Changes at the Resolution of Individual Exons in the Human Genome
Dhami, P., Coffey, A. J., Abbs, S. J., Vermeesch, J. R., Dumanski, J. P., Woodward, K. J., Andrews, R., Langford, C., & Vetrie, D. L. P. (2005) · The American Journal of Human Genetics · doi:10.1086/429588 · Cited by 147
MethyCancer: the database of human DNA methylation and cancer
He, X., Chang, S., Zhang, J., Zhao, Q. P., Xiang, H., Kusonmano, K., Yang, L., Sun, Z. S., Yang, H., & Wang, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm730 · Cited by 141
The importance of p53 pathway genetics in inherited and somatic cancer genomes
Stracquadanio, G., Wang, X., Wallace, M. D., Grawenda, A. M., Zhang, P., Hewitt, J., Zerón-Medina-Cuairán, J., Castro-Giner, F., Tomlinson, I. P. M., Goding, C. R., et al. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.15 · Cited by 143
Prospects for pharmacological targeting of pseudokinases
Kung, J. E., & Jura, N. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0018-3 · Cited by 144
Multifunctional proteins revealed by overlapping clustering in protein interaction network
Becker, E., Robisson, B., Chapple, C. E., Guénoche, A., & Brun, C. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr621 · Cited by 140
Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted Therapies
Astsaturov, I. A., Ratushny, V., Sukhanova, A. L., Einarson, M. B., Bagnyukova, T., Zhou, Y., Devarajan, K., Silverman, J. S., Tikhmyanova, N., Skobeleva, N., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2001083 · Cited by 144
Spatial heterogeneity in medulloblastoma
Morrissy, A. S., Cavalli, F. M. G., Remke, M., Ramaswamy, V., Shih, D. J. H., Holgado, B., Farooq, H., Donovan, L., Garzia, L., Agnihotri, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3838 · Cited by 143
Hierarchical HotNet: identifying hierarchies of altered subnetworks
Reyna, M. A., Leiserson, M. D. M., & Raphael, B. J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty613 · Cited by 142
Integrated Informatics Analysis of Cancer-Related Variants
Pagel, K. A., Kim, R., Moad, K., Busby, B., Zheng, L., Tokheim, C. J., Ryan, M., & Karchin, R. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.19.00132 · Cited by 146
Post-translational modifications and the Warburg effect
Hitosugi, T., & Chen, J. (2013) · Oncogene · doi:10.1038/onc.2013.406 · Cited by 139
The Swedish Family‐Cancer Database 2009: prospects for histology‐specific and immigrant studies
Hemminki, K., Ji, J., Brandt, A., Mousavi, S. M., & Sundquist, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24795 · Cited by 139
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
Robey, R. B., Weisz, J., Kuemmerle, N. B., Salzberg, A. C., Berg, A. S., Brown, D. G., Maurer, L. L., Palorini, R., Al‐Mulla, F., Al-Temaimi, R. A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv037 · Cited by 143
Discovery of microRNAs and other small RNAs in solid tumors
Meiri, E., Levy, A., Benjamin, H., Ben-David, M., Cohen, L., Dov, A., Dromi, N., Elyakim, E., Yerushalmi, N., Zion, O., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq376 · Cited by 141
Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants
Xi, R., Lee, S., Xia, Y., Kim, T., & Park, P. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw491 · Cited by 140
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
Su, G.-H., Xiao, Y., You, C., Zheng, R., Zhao, S., Sun, S., Zhou, J.-Y., Lin, L., Wang, H., Shao, Z., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf0837 · Cited by 140
Properties of Protein Drug Target Classes
Bull, S. C., & Doig, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117955 · Cited by 146
Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors
Ohshima, K., Hatakeyama, K., Nagashima, T., Watanabe, Y., Kanto, K., Doi, Y., Ide, T., Shimoda, Y., TANABE, T., Ohnami, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00219-3 · Cited by 138
DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies
Han, Y., Yang, J., Qian, X., Cheng, W., Liu, S., Hua, X., Zhou, L., Yang, Y., Wu, Q., Liu, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz096 · Cited by 140
Concise Review: Genomic Stability of Human Induced Pluripotent Stem Cells
Martins‐Taylor, K., & Xu, R. (2011) · Stem Cells · doi:10.1002/stem.705 · Cited by 141
No paradox, no progress: inverse cancer comorbidity in people with other complex diseases
Tabarés‐Seisdedos, R., Dumont, N., Baudot, A., Valderas, J. M., Climent, J., Valencia, A., Crespo‐Facorro, B., Vieta, E., Gómez-Beneyto, M., Martı́nez, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70041-9 · Cited by 138
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression
Piscuoglio, S., Ng, C. K. Y., Murray, M. P., Burke, K. A., Edelweiss, M., Geyer, F. C., Macedo, G. S., Inagaki, A., Papanastasiou, A. D., Martelotto, L. G., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4672 · Cited by 138
Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer
Liu, D., Xiong, H., Ellis, A. E., Northrup, N. C., Rodriguez, C. O., O'Regan, R. M., Dalton, S., & Zhao, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0392 · Cited by 135
Universidade Estadual Paulista - UNESP
Filho, J. D. M. (2009) · Cited by 135
Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy
Zhang, C., Wu, W. H., Li, R., Qiu, W., Zhuang, Z., Cheng, S., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201804492 · Cited by 136
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
Bacher, U., Shumilov, E., Flach, J., Porret, N. A., Joncourt, R., Wiedemann, G., Fiedler, M., Novak, U., Amstutz, U., & Pabst, T. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0148-6 · Cited by 136
Proteomic Changes Resulting from Gene Copy Number Variations in Cancer Cells
Geiger, T., Cox, J., & Mann, M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001090 · Cited by 135
Genome-wide DNA Methylation Events in TMPRSS2–ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
Börno, S. T., Fischer, A., Kerick, M., Fälth, M., Laible, M., Brase, J. C., Kuner, R., Dahl, A., Grimm, C., Sayanjali, B., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0041 · Cited by 137
Cytosine methylation profiling of cancer cell lines
Ehrich, M., Turner, J., Gibbs, P., Lipton, L. R., Giovanneti, M., Cantor, C. R., & van den Boom, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712251105 · Cited by 133
Nearby inverted repeats fuse to generate acentric and dicentric palindromic chromosomes by a replication template exchange mechanismPreprint
Mizuno, K., Lambert, S., Baldacci, G., Murray, J. M., & Carr, A. M. (2009) · Genes & Development · doi:10.1101/gad.1863009 · Cited by 147
Towards novel paradigms for cancer therapy
Pavet, V., Portal, M. M., Moulin, J.-F., Herbrecht, R., & Gronemeyer, H. (2010) · Oncogene · doi:10.1038/onc.2010.460 · Cited by 135
CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma
Li, J., Hu, Z., Yu, S., Mao, L., Zhou, Z., Wang, P., Gong, Y., Su, S., Zhou, J., Fan, J., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1259 · Cited by 134
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
Ng, C. K. Y., Martelotto, L. G., Gauthier, A., Wen, H., Piscuoglio, S., Lim, R. S., Cowell, C. F., Wilkerson, P. M., Wai, P. T., Rodrigues, D. N., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0657-6 · Cited by 135
Structural variation in two human genomes mapped at single-nucleotide resolution by whole genome de novo assembly
Li, Y., Zheng, H., Luo, R., Wu, H., Zhu, H., Li, R., Cao, H., Wu, B., Huang, S., Shao, H., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1904 · Cited by 133
Self-citation
Common critical pathways in embryogenesis and cancer
Kelleher, F. C., Fennelly, D. W., & Rafferty, M. (2006) · Acta Oncologica · doi:10.1080/02841860600602946 · Cited by 131
Objective assessment of cancer genes for drug discovery
Patel, M. N., Halling‐Brown, M., Tym, J. E., Workman, P., & Al‐Lazikani, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3913 · Cited by 133
Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
Krisanaprakornkit, S., & Iamaroon, A. (2012) · ISRN Oncology · doi:10.5402/2012/681469 · Cited by 134
Genetic studies of diseases
Wang, E., Lenferink, A. E. G., & O'Connor‐McCourt, M. D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7054-6 · Cited by 128
Genomic profiling reveals mutational landscape in parathyroid carcinomas
Pandya, C., Uzilov, A. V., Bellizzi, J., Lau, C. Y., Moe, A. S., Strahl, M., Hamou, W., Newman, L. C., Fink, M. Y., Antipin, Y., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92061 · Cited by 128
Giant tortoise genomes provide insights into longevity and age-related disease
Quesada, V., Freitas-Rodríguez, S., Miller, J., Pérez-Silva, J. G., Jiang, Z.-F., Tapia, W., Santiago-Fernández, O., Campos-Iglesias, D., Kuderna, L. F. K., Quinzin, M., et al. (2018) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0733-x · Cited by 114
Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology
McDermott, U., & Settleman, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9054 · Cited by 131
Methods for Genomic Partitioning
Turner, E. H., Ng, S. B. H., Nickerson, D. A., & Shendure, J. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150112 · Cited by 131
Homeobox oncogene activation by pan-cancer DNA hypermethylation
Su, J., Huang, Y., Cui, X., Wang, X., Zhang, X., Lei, Y., Xu, J., Lin, X., Chen, K., Lv, J., et al. (2018) · Genome biology · doi:10.1186/s13059-018-1492-3 · Cited by 130
A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces
Porta‐Pardo, E., García‐Alonso, L., Hrabe, T., Dopazo, J., & Godzik, A. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004518 · Cited by 127
High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization
Mantripragada, K. K., Spurlock, G., Kluwe, L., Chuzhanova, N. A., Ferner, R. E., Frayling, I. M., Dumanski, J. P., Guha, A., Mautner, V., & Upadhyaya, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1305 · Cited by 126
CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer
Wong, W. C., Kim, D., Carter, H. K., Diekhans, M., Ryan, M., & Karchin, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr357 · Cited by 125
Uterine adenosarcomas are mesenchymal neoplasms
Piscuoglio, S., Burke, K. A., Ng, C. K. Y., Papanastasiou, A. D., Geyer, F. C., Macedo, G. S., Martelotto, L. G., de Bruijn, I., Filippo, M. R. D., Schultheis, A. M., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4675 · Cited by 125
Mechanisms of chromosome instability in cancers
Jefford, C. E., & Irminger‐Finger, I. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.005 · Cited by 129
Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms
Kaminker, J. S., Zhang, Y., Waugh, A., Haverty, P. M., Peters, B. A., Sebisanovic, D., Stinson, J., Forrest, W. F., Bazán, J. F., Seshagiri, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1736 · Cited by 124
GSK-3 Promotes Conditional Association of CREB and Its Coactivators with MEIS1 to Facilitate HOX-Mediated Transcription and Oncogenesis
Wang, Z., 岩崎, 正., Ficara, F., Lin, C., Matheny, C., Wong, S. H. K., Smith, K. S., & Cleary, M. L. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.024 · Cited by 124
The mutational landscape of chromatin regulatory factors across 4,623 tumor samples
González-Pérez, A., Jené-Sanz, A., & López-Bigas, N. (2013) · Genome biology · doi:10.1186/gb-2013-14-9-r106 · Cited by 131
e-Driver: a novel method to identify protein regions driving cancer
Porta‐Pardo, E., & Godzik, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu499 · Cited by 124
Analysis of somatic microsatellite indels identifies driver events in human tumors
Maruvka, Y. E., Mouw, K. W., Karlić, R., Parasuraman, P., Kamburov, A., Polak, P. P., Haradhvala, N. J., Hess, J. M., Rheinbay, E., Brody, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3966 · Cited by 126
The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders
Willsey, A. J., Morris, M. T., Wang, S., Willsey, H. R., Sun, N., Teerikorpi, N., Baum, T., Cagney, G., Bender, K. J., Desai, T. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.016 · Cited by 129
CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers
Tokheim, C. J., & Karchin, R. (2019) · Cell Systems · doi:10.1016/j.cels.2019.05.005 · Cited by 134
DNA copy number amplification profiling of human neoplasms
Myllykangas, S., Himberg, J., Böhling, T., Nagy, B., Hollmén, J., & Knuutila, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209717 · Cited by 124
The Role of Mechanistic Factors in Promoting Chromosomal Translocations Found in Lymphoid and Other Cancers
Zhang, Y., Gostissa, M., Hildebrand, D. G., Becker, M. S., Boboilă, C., Chiarle, R., Lewis, S. M., & Alt, F. W. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06004-9 · Cited by 135
Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis
Finetti, P., Cervera, N., Charafe‐Jauffret, E., Chabannon, C., Charpin, C., Chaffanet, M., Jacquemier, J. D., Viens, P., Birnbaum, D., & Bertucci, F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5516 · Cited by 123
Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma
Starrett, G. J., Marcelus, C., Cantalupo, P. G., Katz, J. P., Cheng, J., Akagi, K., Thakuria, M., Rabinowits, G., Wang, L. C., Symer, D. E., et al. (2017) · mBio · doi:10.1128/mbio.02079-16 · Cited by 126
A global transcriptional network connecting noncoding mutations to changes in tumor gene expression
Zhang, W., Bojorquez-Gomez, A., Velez, D. O., Xu, G., Sanchez, K. S., Shen, J. P., Chen, K., Licon, K., Melton, C. A., Olson, K. M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0091-2 · Cited by 126
Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT
Lee, J., Kim, H., Lee, J. E., Shin, S., Oh, S., Kwon, G., Kim, H., Choi, Y. H., White, M. A., Paik, S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.024 · Cited by 124
mutation3D: Cancer Gene Prediction Through Atomic Clustering of Coding Variants in the Structural Proteome
Meyer, M. J., Lapcevic, R., Romero, A. E., Yoon, M., Das, J., Beltrán, J. F., Mort, M. E., Stenson, P. D., Cooper, D. N., Paccanaro, A., et al. (2016) · Human Mutation · doi:10.1002/humu.22963 · Cited by 123
Variation Interpretation Predictors: Principles, Types, Performance, and Choice
Niroula, A., & Vihinen, M. (2016) · Human Mutation · doi:10.1002/humu.22987 · Cited by 127
Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice
Viarisio, D., Müller‐Decker, K., Accardi, R., Robitaille, A., Dürst, M., Beer, K., Jansen, L., Flechtenmacher, C., Bozza, M., Harbottle, R. P., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006783 · Cited by 122
Return to the Sea, Get Huge, Beat Cancer: An Analysis of Cetacean Genomes Including an Assembly for the Humpback Whale (Megaptera novaeangliae)
Tollis, M., Robbins, J., Webb, A. E., Kuderna, L. F. K., Caulin, A. F., Garcia, J. D., Bérubé, M., Pourmand, N., Marquès‐Bonet, T., O’Connell, M. J., et al. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz099 · Cited by 127
Robustness and lethality in multilayer biological molecular networks
Liu, X., Maiorino, E., Halu, A., Glass, K., Prasad, R. B., Loscalzo, J., Gao, J., & Sharma, A. (2020) · Nature Communications · doi:10.1038/s41467-020-19841-3 · Cited by 124
Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential
Coughlin, M. F., Bielenberg, D. R., Lenormand, G., Marinkovic, M., Waghorne, C. G., Zetter, B. R., & Fredberg, J. J. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9531-z · Cited by 124
Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability
Li, X., Wu, W. K. K., Xing, R., Wong, S. H., Liu, Y., Fang, X., Zhang, Y., Wang, M., Wang, J., Li, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2443 · Cited by 122
Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure
Tokheim, C. J., Bhattacharya, R., Niknafs, N., Gygax, D. M., Kim, R., Ryan, M. T., Masica, D. L., & Karchin, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3190 · Cited by 123
Comprehensive, integrated, and phased whole-genome analysis of the primary ENCODE cell line K562Preprint
Zhou, B., Ho, S. S., Greer, S., Zhu, X., Bell, J., Arthur, J. G., Spies, N., Zhang, X., Byeon, S., Pattni, R., et al. (2019) · Genome Research · doi:10.1101/gr.234948.118 · Cited by 120
Extreme multifunctional proteins identified from a human protein interaction network
Chapple, C. E., Robisson, B., Spinelli, L., Guien, C., Becker, E., & Brun, C. (2015) · Nature Communications · doi:10.1038/ncomms8412 · Cited by 122
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features
Li, X., Xu, W., Kang, W., Wong, S. H., Wang, M., Zhou, Y., Fang, X., Zhang, X., Yang, H., Wong, C. H., et al. (2018) · Theranostics · doi:10.7150/thno.22010 · Cited by 119
Identifying disease genes and module biomarkers by differential interactions
Liu, X., Liu, Z.-P., Zhao, X., & Chen, L. (2011) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000658 · Cited by 118
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Pitt, J. J., Riester, M., Zheng, Y., Yoshimatsu, T. F., Sanni, A., Oluwasola, O., Veloso, A., Labrot, E., Wang, S., Odetunde, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06616-0 · Cited by 123
Ubiquitin becomes ubiquitous in cancer
Shi, D., & Grossman, S. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.8.13417 · Cited by 123
Comparison of HIV-derived Lentiviral and MLV-based Gammaretroviral Vector Integration Sites in Primate Repopulating Cells
Beard, B. C., Dickerson, D. R., Beebe, K., Gooch, C., Fletcher, J., Okbinoglu, T., Miller, D. G., Jacobs, M. A., Kaul, R., Kiem, H., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300159 · Cited by 121
Comparative analysis of cancer genes in the human and chimpanzee genomes
Puente, X. S., Velasco, G., Gutiérrez‐Fernández, A., Bertranpetit, J., King, M., & López-Otı́n, C. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-15 · Cited by 118
Alterations of the BRAF Gene in Thyroid Tumors
Ciampi, R., & Nikiforov, Y. E. (2005) · Endocrine Pathology · doi:10.1385/ep:16:3:163 · Cited by 117
DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers
Lockwood, W. W., Chari, R., Coe, B. P., Girard, L., MacAulay, C. E., Lam, S. C., Gazdar, A. F., Minna, J. D., & Lam, W. L. (2008) · Oncogene · doi:10.1038/onc.2008.98 · Cited by 120

Authors: Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R.
Affiliations: Wellcome Sanger Institute (GB)
Institute of Cancer Research (GB)
Corresponding author: Stratton, Michael R.
ORCID: Futreal, P. Andrew
Coin, Lachlan
Down, Thomas
Rahman, Nazneen
Stratton, Michael R.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-03
Volume: 4
Issue: 3
Pages: 177-183
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1299
PMC: PMC2665285
OpenAlex: W2102140136
Cited by: 3,184
References: 44
Citations by year: 2026: 13 · 2025: 51 · 2024: 71 · 2023: 134 · 2022: 109 · 2021: 143 · 2020: 166 · 2019: 204 · 2018: 237 · 2017: 190 · 2016: 191 · 2015: 228 · 2014: 201 · 2013: 208 · 2012: 164
FWCI: 7.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: cancer genes, oncogenes, tumor suppressor, oncogenic mutations, mutation frequency, human genome, protein domains, cancer classification
MeSH terms: Genes, Humans, Mutation, Neoplasms, Oncogenes, Genome, Human

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A census of human cancer genes

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks